International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

Key facts

Sponsor

SCAD Alliance

Principal Investigator

Esther Kim, MD

Chair, Steering Committee

Enrollment

1000 target

Eligibility

18 years · All sexes

Timeline

2019 – 2025

Study locations (30)

• Cedars Sinai, Los Angeles, California, United States
• UCLA (University of California, Los Angeles), Los Angeles, California, United States
• Kaiser Permanente Northern California, San Francisco, California, United States
• University of Colorado, Aurora, Colorado, United States
• Hartford Hospital, Hartford, Connecticut, United States
• University of South Florida, Tampa, Florida, United States
• Emory Healthcare System, Atlanta, Georgia, United States
• Northwestern Medicine, Chicago, Illinois, United States
• University of Kentucky, Lexington, Kentucky, United States
• Johns Hopkins, Baltimore, Maryland, United States
• Massachusetts General Hospital, Boston, Massachusetts, United States
• St. Luke's Mid America, Kansas City, Missouri, United States
• Washington University, St Louis, Missouri, United States
• Dartmouth-Hitchcock, Lebanon, New Hampshire, United States
• Catholic Medical Center, Manchester, New Hampshire, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

PERFUSE Study Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Idiopathic spontaneous coronary artery dissection

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNCT04936438
  Clinical Cohort Study - INTERCATH
  University of Hamburg-Eppendorf

See all trials for Idiopathic spontaneous coronary artery dissection →